Grünwald-Letnikov scheme for system of chronic myelogenous leukemia fractional differential equations and its optimal control of drug treatment

DOI10.22103/JMMRC.2017.1567MaRDI QIDQ4625820zbMATH OpenOpenAlexFDO

Authors Esmail Hesameddini, Mahin Azizi

Publication date 25 February 2019

Full work available at URL https://jmmrc.uk.ac.ir/article_1567_8df675cb23ef6decdb2b1b7484bbe575.pdf

zbMATH Keywords

stabilityfractional differential equationsmyelogenous leukemia blood cancer

Mathematics Subject Classification ID

Medical applications (general) (92C50) Fractional ordinary differential equations (34A08)

Recommendations

• A new fractional model and optimal control of a tumor-immune surveillance with non-singular derivative operator
• A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies
• A fractional‐order model for chronic lymphocytic leukemia and immune system interactions
• Optimal control for a nonlinear mathematical model of tumor under immune suppression: a numerical approach
• Optimal control for cancer treatment mathematical model using Atangana-Baleanu-Caputo fractional derivative

Cited in

(4)

• Optimal control for a nonlinear mathematical model of tumor under immune suppression: a numerical approach
• Comparative study for optimal control nonlinear variable-order fractional tumor model
• Numerical solution and optimal control for fractional tumor immune model
• scientific article; zbMATH DE number 7529804 (Why is no real title available?)

This page was built for publication: Grünwald-Letnikov scheme for system of chronic myelogenous leukemia fractional differential equations and its optimal control of drug treatment

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4625820)